These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
711 related items for PubMed ID: 16709383
21. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. Reboldi G, Angeli F, Cavallini C, Gentile G, Mancia G, Verdecchia P. J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998 [Abstract] [Full Text] [Related]
22. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT). White HD, Aylward PE, Huang Z, Dalby AJ, Weaver WD, Barvik S, Marin-Neto JA, Murin J, Nordlander RO, van Gilst WH, Zannad F, McMurray JJ, Califf RM, Pfeffer MA, VALIANT Investigators. Circulation; 2005 Nov 29; 112(22):3391-9. PubMed ID: 16301343 [Abstract] [Full Text] [Related]
25. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction. Austin PC, Tu JV, Ko DT, Alter DA. CMAJ; 2008 Oct 21; 179(9):901-8. PubMed ID: 18936455 [Abstract] [Full Text] [Related]
26. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)]. Magrini G, Nicolosi GL, Chiariello M, Ferrari R, Remme P, Tavazzi L. Ital Heart J; 2005 Nov 21; 6 Suppl 7():14S-23S. PubMed ID: 16485513 [Abstract] [Full Text] [Related]
27. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study. Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM. Can J Cardiol; 2005 May 01; 21(6):485-8. PubMed ID: 15917876 [Abstract] [Full Text] [Related]
28. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis. van der Elst ME, Bouvy ML, de Blaey CJ, de Boer A. Clin Ther; 2005 Nov 01; 27(11):1806-14. PubMed ID: 16368451 [Abstract] [Full Text] [Related]
29. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence. Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L. Am Heart J; 2003 Mar 01; 145(3):438-44. PubMed ID: 12660666 [Abstract] [Full Text] [Related]
30. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC. J Am Coll Cardiol; 2008 Apr 01; 51(13):1247-54. PubMed ID: 18371553 [Abstract] [Full Text] [Related]
35. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers. Pascual-Figal DA, Redondo B, Caro C, Manzano S, Garrido IP, Ruipérez JA, Valdés M. Am J Cardiol; 2008 Dec 15; 102(12):1711-7. PubMed ID: 19064029 [Abstract] [Full Text] [Related]
36. Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000. Pilote L, Beck CA, Karp I, Alter D, Austin P, Cox J, Humphries K, Jackevicius C, Richard H, Tu JV, Canadian Cardiovascular Outcomes Research Team. Can J Cardiol; 2004 Jan 15; 20(1):61-7. PubMed ID: 14968144 [Abstract] [Full Text] [Related]